Disruptive Technology Content Hub Dark Genes Shine Light on Genomics ETF Opportunity By Tom LydonSeptember 23, 2020
Disruptive Technology Content Hub Why This Genomics ETF Is a Long-Term Winner By Tom LydonSeptember 15, 2020
Disruptive Technology Content Hub CRISPR Benefits Available in This Genomics ETF By Tom LydonSeptember 10, 2020
Disruptive Technology Content Hub Another Exciting Growth Could Lift Long-Term Genomics Outlook By Tom LydonSeptember 3, 2020
Disruptive Technology Content Hub Make the CRISPR Call With This Genomics ETF By Tom LydonAugust 25, 2020
Disruptive Technology Content Hub An Important Sequel, not the Usual Kind, in a Hot Genomics ETF By Tom LydonAugust 18, 2020
Thematic Investing Content Hub The Genomics Market is Poised for Growth Through 2025 By Ben HernandezAugust 17, 2020
Disruptive Technology Content Hub Compelling Reasons to Love ARK Genomics ETF ‘ARKG’ By Todd ShriberAugust 13, 2020
Disruptive Technology Content Hub Making Room in the ARK for Other Equity ETFs By Todd RosenbluthAugust 13, 2020
Disruptive Technology Content Hub Precision Power Boosts Case for Genomics ETF By Tom LydonJuly 24, 2020
Disruptive Technology Content Hub Genomics Long-Term Trajectory Shines a Light on ARKG By Tom LydonJuly 10, 2020
Disruptive Technology Content Hub ARK Invest: The Rise of the Importance of Virtual Care Amid Covid-19 By Aaron NeuwirthJuly 8, 2020
Disruptive Technology Content Hub ETF of the Week: ARK Genomic Revolution Multi-Sector Fund (ARKG) By Aaron NeuwirthJuly 2, 2020
Disruptive Technology Content Hub Coronavirus Flareup Sparked a Great Week for Active Genomics ETF By Tom LydonJune 29, 2020
Innovative ETFs Content Hub Biotech ETFs Rally After Inovio Locks in DOD Coronavirus Deal By Max ChenJune 23, 2020
Innovative ETFs Content Hub Biotech ETFs Surge After Invitae Acquires ArcherDX By Max ChenJune 22, 2020
Innovative ETFs Content Hub This Genomics ETF is Performing Like a Freak of Nature By Ben HernandezMay 27, 2020
